HIGHLIGHTS
- What: The authors could not evaluate resistance to cefiderocol until 2023, using the microdilution method, according to EUCAST , the sensitivity level for Cr-Kpn isolates being 60%. This study evaluated 172 patients admitted between January 2022 and October 2023, from which stems of Cr-Kpn were isolated. Limitation of This study: This study was conducted in a hospital exclusively treating patients with infectious diseases, and the results obtained cannot be extrapolated to general hospitals. This study compared the characteristics and evolution of the patients, having as the main discriminator the type of carbapenemase encountered due to the . . .

If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.